Stock Price
120.70
Daily Change
-3.86 -3.10%
Monthly
7.88%
Yearly
-16.46%
Q3 Forecast
123.53

Repligen reported $32.18M in EBITDA for its fiscal quarter ending in June of 2025.




Ebitda Change Date
Agilent USD 466M 14M Jul/2025
Align Technology USD 137.61M 77.61M Mar/2025
Bio Techne USD 115.58M 47.73M Jun/2025
BioMarin Pharmaceutical USD 295.45M 49.49M Jun/2025
Bristol-Myers Squibb USD 3.27B 1.63B Jun/2025
Bruker USD 128.1M 27.1M Jun/2025
Charles River Laboratories USD 220.89M 2.01M Jun/2025
Danaher USD 1.34B 543M Jun/2025
Dentsply International USD 197M 45M Jun/2025
Exact Sciences USD 138.22M 173.88M Jun/2025
General Electric Aerospace USD 2.1B 720M Mar/2025
Henry Schein USD 256M 0 Jun/2025
Illumina USD 399M 168M Jun/2025
IQVIA Holdings USD 910M 112M Jun/2025
Mettler Toledo International USD 295.89M 43.87M Jun/2025
Myriad Genetics USD -17800000 15.7M Mar/2025
Pfizer USD 5.32B 889M Jun/2025
Repligen USD 32.18M 9.36M Jun/2025
Revvity USD 209.29M 22.24M Jun/2025
Standard Biotools USD -14279000 11.5M Jun/2025
Thermo Fisher Scientific USD 3.06B 541M Jun/2025
Waters USD 276.28M 74.81M Jun/2025
West Pharmaceutical Services USD 164.8M 43.8M Mar/2025